- May 24, 2022
FDA Approves Vidaza for Rare Pediatric Blood Cancer
The Food and Drug Administration (FDA) approved Vidaza (azacytidine) for the treatment of pediatric patients with newly diagnosed...
- Sep 13, 2019
How a Powerful Genetic Test Matched An Infant’s Cancer to a Life-Saving Therapy
Doctors have successfully treated an infant with a rare childhood leukemia using a targeted therapy approved for adults with inoperable...
- Dec 20, 2017
Childhood Leukemia Outcomes May Be Informed by DNA Methylation Patterns
Two studies by independent research teams have identified epigenetic subgroups in children with a rare pediatric leukemia called juvenile...
- Oct 20, 2015
UAMS Cancer Researchers Publish Findings on Rare Childhood Leukemia
New findings on juvenile myelomonocytic leukemia (JMML) by researchers at the University of Arkansas for Medical Sciences (UAMS) and...